HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

enzastaurin

protein kinase Cbeta-selective inhibitor; structure in first source
Also Known As:
LY317615.HCl
Networked: 137 relevant articles (19 outcomes, 71 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Musib, Luna: 11 articles (06/2010 - 08/2005)
2. Thornton, Donald: 8 articles (06/2013 - 08/2005)
3. Civallero, Monica: 6 articles (10/2012 - 07/2008)
4. Cosenza, Maria: 6 articles (10/2012 - 07/2008)
5. Lahn, Michael: 6 articles (06/2009 - 08/2007)
6. Shi, Peipei: 5 articles (07/2014 - 07/2011)
7. Sacchi, Stefano: 5 articles (10/2012 - 07/2008)
8. Anderson, Kenneth C: 5 articles (07/2011 - 02/2007)
9. Chang, Susan M: 4 articles (12/2015 - 06/2010)
10. Butowski, Nicholas: 4 articles (12/2015 - 06/2010)

Related Diseases

1. Neoplasms (Cancer)
2. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
3. Lymphoma (Lymphomas)
4. Glioma (Gliomas)
5. Ovarian Neoplasms (Ovarian Cancer)

Related Drugs and Biologics

1. pemetrexed (MTA)
2. Carboplatin (JM8)
3. docetaxel (Taxotere)
4. Paclitaxel (Taxol)
5. Cisplatin (Platino)
6. Protein Kinases (Protein Kinase)
7. temsirolimus
8. everolimus
9. lenalidomide (CC 5013)
10. Lomustine (CCNU)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Heterologous Transplantation (Xenotransplantation)
3. Radiotherapy
4. Castration
5. Chemoprevention